Literature DB >> 32394485

Linking process indicators and clinical/safety outcomes to assess the effectiveness of abatacept (ORENCIA) patient alert cards in patients with rheumatoid arthritis.

Esther Artime1, Randip Kahlon2, Ignacio Méndez1, Tzuyung Kou3, Macarena Garrido-Estepa1, Nawab Qizilbash1,4.   

Abstract

PURPOSE: Patient alert cards (PACs) for abatacept (ORENCIA) inform patients and healthcare professionals (HCPs) about the risk of infections and allergic reactions. The study evaluates the effectiveness of the PACs in rheumatoid arthritis patients and HCPs, using process indicators (awareness, receipt, utility, knowledge, behaviour) and outcomes.
METHODS: Surveys of patients and HCPs in five European countries. A retrospective chart review permitted linking clinical and safety outcomes with survey responses.
RESULTS: Data on 190 patients and 79 HCPs (50 physicians and 29 nurses) were analysed. Sixty percent of patients were aware of the PAC, of whom 95% had received it. Knowledge of risk of infection was higher among patients who had received the PAC vs those who had not (64% vs 46%; P = .013). Infections leading to hospitalisation increased with decreasing patient survey global scores: scores of ≥67%, 34%-67% and ≤ 33% were associated with hospitalisation rates of 2.5%, 5.2% and 8.4%, respectively (P = .4). Among HCPs 90% were aware and 68% had accessed the PAC. More nurses than physicians were aware (93% vs 88%), had accessed (78% vs 74%), read (90% vs 59%), distributed (81% vs 66%) and explained the content (94% vs 43%) of the PAC. Knowledge of risk of infection was higher among HCPs who had (91%) vs those who had not (73%) accessed the PAC (P = .053).
CONCLUSIONS: PACs were effective in improving knowledge of key safety messages in patients and HCPs. This novel study design bridges the gap of linking process indicators with outcomes in the same patients, thereby strengthening the clinical relevance of patient surveys.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  PASS; educational material; effectiveness evaluation; patient alert card; pharmacoepidemiology; risk minimisation; survey

Mesh:

Substances:

Year:  2020        PMID: 32394485     DOI: 10.1002/pds.5012

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  2 in total

1.  Pharmacists' perception of educational material to improve patient safety: A cross-sectional study on practices and awareness in Germany.

Authors:  André Said; Leonard Freudewald; Natalie Parrau; Matthias Ganso; Martin Schulz
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

2.  Effectiveness of Additional Risk Minimization Measures for Atezolizumab in the European Union.

Authors:  Hina Patel; Thanh G N Ton; Jessica Davies; Simon Fear; Carolin Block; Kunihiko Tanaka; Danny Gonzalez; Roger Mutter; Noelia Alfaro-Oliver; Ignacio Mendez; Nawab Qizilbash
Journal:  Pharmaceut Med       Date:  2021-12-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.